These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28107839)

  • 41. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Combination therapy of atherogenic dyslipidemias in women].
    Tkacheva ON; Galiautdinova AIu
    Kardiologiia; 2008; 48(4):66-70. PubMed ID: 18447845
    [No Abstract]   [Full Text] [Related]  

  • 43. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2024 Oct; 10(6):479-480. PubMed ID: 39364572
    [No Abstract]   [Full Text] [Related]  

  • 46. Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report.
    Okeahialam BN
    Vasc Health Risk Manag; 2015; 11():579-81. PubMed ID: 26604775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome].
    Millán Núñez-Cortés J; Montoya JP; Salas XP; Hernández Mijares A; Carey VJ; Hermans MP; Sacks FM; Fruchart JC
    Endocrinol Nutr; 2011 Jan; 58(1):38-47. PubMed ID: 21208833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacodynamic and clinical trial evidence for statin dose.
    Dimmitt SB; Stampfer HG; Warren JB
    Br J Clin Pharmacol; 2018 Jun; 84(6):1128-1135. PubMed ID: 29393975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficacy of simvastatin in elderly patients with type 2 diabetes].
    Gonokhova LG
    Kardiologiia; 2006; 46(8):29-32. PubMed ID: 17058344
    [No Abstract]   [Full Text] [Related]  

  • 50. Trisomy of the Short Arm of Chromosome 12 Associated with High Cardiovascular Risk: A Case Report.
    Fulcheri C; Balietti P; Rabbia F; Schiavone D; Magnino C; Abate Daga F; Gollin M; Veglio F
    High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):143-144. PubMed ID: 30806948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ezetimibe/statin combination therapy to treat patients with type 2 diabetes.
    Farnier M
    Atheroscler Suppl; 2015 Feb; 17():2-8. PubMed ID: 25659869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ; Park SE; Oh HG; Park CY; Oh KW; Park SW; Blankstein R; Plutzky J; Lee WY
    Atherosclerosis; 2015 May; 240(1):242-9. PubMed ID: 25818250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does statin use cause memory decline in the elderly?
    Samaras K; Brodaty H; Sachdev PS
    Trends Cardiovasc Med; 2016 Aug; 26(6):550-65. PubMed ID: 27177529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Will obesity increase the proportion of children and adolescents recommended for a statin?
    McCrindle BW; Tyrrell PN; Kavey RE
    Circulation; 2013 Nov; 128(19):2162-5. PubMed ID: 24190936
    [No Abstract]   [Full Text] [Related]  

  • 57. Rate of Statin Prescription in Younger Patients With Severe Dyslipidemia.
    Al-Kindi SG; DeCicco A; Longenecker CT; Dalton J; Simon DI; Zidar DA
    JAMA Cardiol; 2017 Apr; 2(4):451-452. PubMed ID: 28052161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.
    Gonzalez L; Helkin A; Gahtan V
    Vasc Endovascular Surg; 2016 Feb; 50(2):119-35. PubMed ID: 26983668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
    Gitt AK; Lautsch D; Ferrieres J; Kastelein J; Drexel H; Horack M; Brudi P; Vanneste B; Bramlage P; Chazelle F; Sazonov V; Ambegaonkar B
    Atherosclerosis; 2016 Dec; 255():200-209. PubMed ID: 27667299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.